From trainee to consultant, BMJ Group offers doctors around the world tailored information, special events, learning resources
and recruitment services at every step along their career path.
High-quality CME / CPD for doctors and other healthcare professionals. BMJ Learning features hundreds of accredited, peer-reviewed
learning modules in text, video, and audio formats. Find out more
BMJ Masterclasses, led by experts, help clinicians to use the latest evidence and recent guidelines in practice and meet their
CPD/CME requirements. Find out more
Exam Preparation
The leading provider of online exam preparation, helping over 167,000 healthcare professionals to pass their exams. Find out more
BMJ Careers makes it easy for you to find the right job with the latest healthcare vacancies, upcoming careers fairs, advice
on choosing the right specialty, pay and working conditions.
18-19 October 2013 at the Business Design Centre in Islington, London. Register here
Detection of t(14;18) carrying cells in bone marrow and peripheral blood from patients affected by non-lymphoid diseases.
Mol Path 1998;51:6 333-338doi:10.1136/mp.51.6.333
Detection of t(14;18) carrying cells in bone marrow and peripheral blood from patients affected by non-lymphoid diseases.
Mol Path 1998;51:6 333-338doi:10.1136/mp.51.6.333
Detection of t(14;18) carrying cells in bone marrow and peripheral blood from patients affected by non-lymphoid diseases.
Mol Path 1998;51:6 333-338doi:10.1136/mp.51.6.333
Identification of a novel PTEN mutation (L139X) in a patient with Cowden disease and Sjögren's syndrome. Mol Path 1998;51:6 339-341doi:10.1136/mp.51.6.339
Detection of t(14;18) carrying cells in bone marrow and peripheral blood from patients affected by non-lymphoid diseases.
Mol Path 1998;51:6 333-338doi:10.1136/mp.51.6.333
Detection of t(14;18) carrying cells in bone marrow and peripheral blood from patients affected by non-lymphoid diseases.
Mol Path 1998;51:6 333-338doi:10.1136/mp.51.6.333
Identification of a novel PTEN mutation (L139X) in a patient with Cowden disease and Sjögren's syndrome. Mol Path 1998;51:6 339-341doi:10.1136/mp.51.6.339
Gel staining methods for detection of telomerase activity with the telomeric repeat amplification protocol (TRAP) assay. Mol Path 1998;51:6 342doi:10.1136/mp.51.6.342
Gel staining methods for detection of telomerase activity with the telomeric repeat amplification protocol (TRAP) assay. Mol Path 1998;51:6 342doi:10.1136/mp.51.6.342
Detection of t(14;18) carrying cells in bone marrow and peripheral blood from patients affected by non-lymphoid diseases.
Mol Path 1998;51:6 333-338doi:10.1136/mp.51.6.333
Identification of a novel PTEN mutation (L139X) in a patient with Cowden disease and Sjögren's syndrome. Mol Path 1998;51:6 339-341doi:10.1136/mp.51.6.339
Identification of a novel PTEN mutation (L139X) in a patient with Cowden disease and Sjögren's syndrome. Mol Path 1998;51:6 339-341doi:10.1136/mp.51.6.339
Detection of t(14;18) carrying cells in bone marrow and peripheral blood from patients affected by non-lymphoid diseases.
Mol Path 1998;51:6 333-338doi:10.1136/mp.51.6.333
Identification of a novel PTEN mutation (L139X) in a patient with Cowden disease and Sjögren's syndrome. Mol Path 1998;51:6 339-341doi:10.1136/mp.51.6.339
Gel staining methods for detection of telomerase activity with the telomeric repeat amplification protocol (TRAP) assay. Mol Path 1998;51:6 342doi:10.1136/mp.51.6.342
Gel staining methods for detection of telomerase activity with the telomeric repeat amplification protocol (TRAP) assay. Mol Path 1998;51:6 342doi:10.1136/mp.51.6.342
